Brachytherapy

In the 1960’s, the permanent insertion of radioactive material into the prostate gland developed. Doctors tried the interstitial insertion of gold -198 or Iodine - 125 seeds into the prostate gland in conjunction with EBRT. Unfortunately, the success of these techniques was poor due to the inability to see the prostate gland and the surrounding organs. Not until around 1980’s, when doctors began to use a transperineal needle temple, transperineal needles, and the transrectal ultrasound, did Brachytherapy become a viable prostate cancer treatment.

Types Of Prostate Brachytherapy

There are two types of Brachytherapy that are used in the treatment of prostate cancer: Permanent Low Dose Radiation (LDR) and Temporary High Dose Radiation (HDR).

LDR Brachytherapy uses iodine -125 and palladium -103 stored in titanium cases, usually referred to as Brachytherapy Seeds. As the name Permanent Brachytherapy suggest, the seeds are permanently left inside the prostate gland. Over the course of their radioactive lives, the seeds will continuously emit low levels of radiation.

HDR Brachytherapy uses a single radioactive seed made of iridium -194, which is sometimes referred to as an iridium wire. Soft flexible plastic catheters are inserted through the perineum, and into the prostate gland. HDR Brachytherapy entails an overnight stay in the hospital, during which a patient undergoes two or three treatments with the wire through each catheter.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Fathers Day Walk Run 2019

Raymond James Father's Day Walk Run Fundraiser, June 16, 2019

The 21st Annual Raymond James Walk Run fundraiser for Prostate Cancer Foundation BC took place on Sunday June 16, 2019 in various locations across BC. The sponsorship page is still accepting donations;  click here to sponsor our Centre's team (opens in new window).

 

Employment

Work at the Vancouver Prostate Centre

Monday, July 8, 2019

Dr. Flannigan to lead clinical trial for scrotal pain treatment

Dr. Flannigan
Monday, June 3, 2019

Benefits Seen With Apalutamide Plus ADT in Metastatic Castration-Sensitive Prostate Cancer

Dr. Chi